Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Estrogen Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00001848
What this trial is testing

The Safety and Effectiveness of Surgery With or Without Raloxifene for the Treatment of Pelvic Pain Caused by Endometriosis

Who this might be right for
EndometriosisPelvic Pain
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 612
Post-approval studies (Phase 4)Study completedNCT00649090
What this trial is testing

Evaluate the Safety of Adjuvant Treatment With Exemestane Following Previous Treatment With Tamoxifen in Postmenopausal Women With Estrogen Sensitive Primary Breast Cancer

Who this might be right for
Breast Neoplasms
Pfizer 1,549
Not applicableStudy completedNCT05392985
What this trial is testing

Detection and Analysis of MBC With Heterogeneous ER Expression

Who this might be right for
Breast Cancer
Fudan University 51
Large-scale testing (Phase 3)Study completedNCT00004650
What this trial is testing

Phase III Randomized Study of the Effect of Postmenopausal Estrogen Replacement Therapy on Alveolar Bone Loss

Who this might be right for
Osteoporosis
National Institute of Dental and Craniofacial Research (NIDCR) 150
Early research (Phase 1)Study completedNCT00318318
What this trial is testing

Beneficial Effects of Oral Premarin Estrogen Replacement Therapy Assessed by Human Genome Array

Who this might be right for
HealthyEstrogen Replacement Therapy
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 20
Large-scale testing (Phase 3)Study completedNCT00256698
What this trial is testing

Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination Therapy

Who this might be right for
Breast Cancer
AstraZeneca 514
Testing effectiveness (Phase 2)Ended earlyNCT04190056
What this trial is testing

Pembrolizumab and Tamoxifen With or Without Vorinostat for the Treatment of Estrogen Receptor Positive Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Prognostic Stage IV Breast Cancer AJCC v8
University of California, San Francisco 1
Post-approval studies (Phase 4)Study completedNCT05469204
What this trial is testing

Effect of Estrogen Treatment on Drug Metabolism and Transport

Who this might be right for
Transgender Persons
University of Washington 22
Large-scale testing (Phase 3)Looking for participantsNCT07062965
What this trial is testing

Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

Who this might be right for
Breast Cancer
Pfizer 400
Post-approval studies (Phase 4)Study completedNCT00224094
What this trial is testing

A Comparison of Patch vs. Pill Estrogen Therapy on Testosterone Levels and Thyroid Tests in Menopausal Women

Who this might be right for
Menopause
Watson Pharmaceuticals 27
Not applicableStudy completedNCT00968214
What this trial is testing

Study of Tumor and Blood Samples From Postmenopausal Women With Primary Breast Cancer Enrolled on Clinical Trial CAN-NCIC-MA27

Who this might be right for
Breast Cancer
Alliance for Clinical Trials in Oncology 364
Not applicableStudy completedNCT00097058
What this trial is testing

Estrogen Use in Protection From Cognitive Decline

Who this might be right for
AgingMenopause
Stanford University 71
Large-scale testing (Phase 3)Study completedNCT00140998
What this trial is testing

Estrogen Treatment (Oral vs. Patches) in Turner Syndrome

Who this might be right for
Turner SyndromeHypogonadismPremature Ovarian Failure
Nemours Children's Clinic 16
Not applicableNot Yet RecruitingNCT05483634
What this trial is testing

Compare Vaginal Estrogen and Platelet-rich Plasma Over Women With Genitourinary Syndrome of Menopause

Who this might be right for
MenopausePlatelet-rich PlasmaEstrogen Replacement Therapy+1 more
Mackay Memorial Hospital 40
Large-scale testing (Phase 3)Study completedNCT00327769
What this trial is testing

Faslodex Advanced Breast Cancer Local Chinese Study

Who this might be right for
Advanced Breast Cancer
AstraZeneca 234
Post-approval studies (Phase 4)Study completedNCT06924229
What this trial is testing

Corneal Changes in Estrogen-Dependent Breast Cancer After Hormonal Treatment

Who this might be right for
Braest CancerDry Eye
Sohag University 40
Post-approval studies (Phase 4)Active Not RecruitingNCT06353269
What this trial is testing

Adherence to Vaginal Estrogen Therapy in Hypoestrogenic Women With Recurrent Urinary Tract Infections

Who this might be right for
Recurrent Urinary Tract InfectionHypoestrogenism
University of California, Irvine 111
Not applicableStudy completedNCT06830486
What this trial is testing

Effects of Activity on Diabetes Risk Among Breast Cancer Survivors on Endocrine Therapy (ABIDE)

Who this might be right for
Breast Cancer
University of Colorado, Denver 40
Testing effectiveness (Phase 2)UnknownNCT00919919
What this trial is testing

Efficacy and Tolerability Study of Progesterone Vaginal Tablets (Endometrin®) in Menopausal Women Treated by Estrogen

Who this might be right for
Endometrial HyperplasiaEndometrial Cancer
Rabin Medical Center 60
Testing effectiveness (Phase 2)Ended earlyNCT01394211
What this trial is testing

Neo-adjuvant Therapy With Anastrozole Plus Pazopanib in Stage II and III ER+ Breast Cancer

Who this might be right for
Estrogen Receptor-positive Breast CancerHuman Epidermal Growth Factor 2 Negative Carcinoma of BreastMale Breast Cancer+4 more
University of Arizona 2
Next Page